Status:

UNKNOWN

Herbal Tea in the Treatment of Type 2 Diabetes Mellitus

Lead Sponsor:

Composite Interceptive Med Science

Collaborating Sponsors:

Composite Interceptive Med-Science Laboratories Pvt Ltd

Conditions:

Type 2 Diabetes Mellitus

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Diabetes mellitus is a chronic disease caused by inherited and/or acquired deficiency in production of insulin by the pancreas, or by the ineffectiveness of the insulin produced. It has become a major...

Eligibility Criteria

Inclusion

  • Adults aged over 18 years and having a diagnosis of diabetes and meeting one of the following criteria
  • Fasting Plasma Glucose ≥126 mg/dL, fasting defined as no caloric intake for at least 8 hours, AND
  • 2-h Post load Glucose ≥140 mg/dL during an OGTT. AND
  • Glycosylated haemoglobin (A1C) ≥ 6.5 %.

Exclusion

  • Any one of the following
  • Patients on Insulin therapy.
  • Patients on oral hypoglycemic agents other than metformin
  • Any history suggestive of micro vascular or macro vascular disease - coronary artery disease, stroke, peripheral artery disease or diabetes related retinal changes.
  • Women in child bearing age unable to practice any form of contraception
  • Patients with diagnosis of Anaemia (Hemoglobin \<11 g/dl in Female and \<13 g/dl in Male)
  • Impaired renal function; estimated glomerular function \<60mls/min/1.73m2.
  • Known history of any chronic illness taking regular pharmacological agents.
  • Blood pressure fluctuations exceeding 20 mmHg on 2 subsequent clinic visits or known history of hypotension or bradycardia in last 6 months or taking 3 or more antihypertensive medications regularly in the last 6 weeks
  • Known history of autonomic dysfunction like diabetic autonomic neural imbalance or neuropathy
  • Participating in another clinical trial with an active intervention or drug or device with last dose taken within 60 days.

Key Trial Info

Start Date :

January 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 20 2019

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT03787563

Start Date

January 1 2019

End Date

January 20 2019

Last Update

December 26 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Health India Hospital

Bangalore, Karnataka, India, 560029

Herbal Tea in the Treatment of Type 2 Diabetes Mellitus | DecenTrialz